Establishment Labs (NASDAQ:ESTA) Releases Earnings Results, Beats Expectations By $0.13 EPS

Establishment Labs (NASDAQ:ESTA) issued its quarterly earnings data on Tuesday. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.13, FiscalAI reports. The business had revenue of $64.62 million for the quarter, compared to analysts’ expectations of $63.80 million. Establishment Labs had a negative net margin of 43.45% and a negative return on equity of 235.45%.

Establishment Labs Stock Down 1.4%

ESTA stock opened at $74.96 on Tuesday. The firm has a market cap of $2.18 billion, a PE ratio of -26.39 and a beta of 0.99. Establishment Labs has a 12 month low of $26.56 and a 12 month high of $78.25. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10. The firm has a 50 day simple moving average of $70.88 and a 200 day simple moving average of $57.41.

Institutional Investors Weigh In On Establishment Labs

Institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC boosted its stake in shares of Establishment Labs by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock worth $1,105,000 after acquiring an additional 299 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Establishment Labs by 1.8% during the fourth quarter. Swiss National Bank now owns 34,200 shares of the company’s stock valued at $2,492,000 after purchasing an additional 600 shares during the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of Establishment Labs during the fourth quarter valued at $47,000. Private Advisor Group LLC boosted its position in shares of Establishment Labs by 14.1% in the 3rd quarter. Private Advisor Group LLC now owns 5,450 shares of the company’s stock valued at $223,000 after purchasing an additional 675 shares during the period. Finally, Quarry LP purchased a new position in Establishment Labs in the 3rd quarter worth about $34,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on ESTA shares. Canaccord Genuity Group boosted their price target on shares of Establishment Labs from $72.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Needham & Company LLC reiterated a “buy” rating and set a $84.00 price objective on shares of Establishment Labs in a research note on Monday, January 12th. Mizuho boosted their target price on Establishment Labs from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Weiss Ratings restated a “sell (e+)” rating on shares of Establishment Labs in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. increased their price target on Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $78.86.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.